Advertise
NEWSLETTER
HCW Biologics wins key U.S....
Scribe Therapeutics starts ...
Rapalogix Health opens Prin...
China approves Leqembi subc...
FibroBiologics granted US p...
HCW Biologics wins key U.S....
Scribe Therapeutics starts ...
Rapalogix Health opens Prin...
China approves Leqembi subc...
FibroBiologics granted US p...
mitochondrial dysfunction

BPGbio moves closer to Phase 3 in rare mitochondrial disease

MitoRx’s new obesity drug targets metabolism, not appetite

Mission lands $13.3m to combat Parkinson’s via mitophagy

Is this mitochondria’s big moment?

Cellvie lands funding to advance therapeutic mitochondria transplantation

NRG lands $67m to combat mitochondrial dysfunction in neurodegeneration

Mito Fund invests in biotech targeting mitochondrial dysfunction

Minovia lands funding to develop mitochondria biomarkers

Longevity biotech Minovia plans $180m SPAC

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form